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BACKGROUND: Directly observed treatment remains one of the most widely-accepted global health 
interventions for tuberculosis. Tuberculosis treatment outcome is one of the performance indicators of 
the programme set by World Health Organization. Therefore, evaluating the treatment success rate 
ofDebreBerhanHospital was mandatory to show the achievement and to indicate where the hospital is 
against the World Health Organization target. 
METHODS: A register based cross sectional study covering the period of January 2009 to December 
2013 was employed. All clients with complete records of the treatment outcome were included in the 
study. A checklist was prepared to extract data from patient charts. Data were entered into Epi-info 
version 3.2.2andanalyzed using SPSS version 16 for windows.  
RESULT: Between January 2009 and December 2013, a total of 1280 tuberculosis cases that had 
complete records on treatment outcome were included in the analysis. Four in five (79.4%) of the 
patients had favorable treatment outcome; 15.8% were cured and 63.5%completed their treatment. There 
was a continuous increment of treatment success rate from 2010 to 2013 in the area and the treatment 
success rate in the year 2013 was 84.4%.  
CONCLUSION: Despite the recent improvements in treatment success rate, treatment completed and 
defaulting rate, further efforts should be made by responsible bodies to identify and improve possible 
promoting factors for successful tuberculosis treatment outcome.  





Tuberculosis is an infectious disease caused by 
Bacillus Mycobacterium Tuberculosis. The 
disease mainly affects the lung (pulmonary 
tuberculosis). However, it can also affect other 
parts of human body (extra pulmonary 
tuberculosis) (1). 
Directly Observed Treatment (DOTS) 
remains one of the most widely-accepted global 
health interventions for tuberculosis. The targets 
of DOTs are to achieve a case detection rate 
(CDR) of 84 % (of all forms of TB) and treatment 
success rates (TSR) of 87% by 2015(1). With 
regard to the burden of tuberculosis,  Ethiopia is 
among the top sixteen countries in the world and 
the three countries in Africa (2). And, it is also the 
leading cause of morbidity, the third cause of 
hospital admission and the second cause of death 
in Ethiopia (2). 
Treatment outcome and detection rate are the 
performance indicators of DOTs programme set 
by World Health Organization (WHO)(3, 4) of 
which reaching a treatment success rate of 87% by 
2015 waslaunched as a target by WHO(3).Disease 
surveillance system and treatment outcome 
monitoring are considered as the key source of 
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evidence to evaluate the effectiveness of 
tuberculosis prevention and control programmes 
like DOTs (5). 
In Ethiopia, Directly Observed Treatment, 
short Course (DOTs) was introduced in 1992 as a 
pilot, and further scaled up at national level. 
Though, the health facility coverage is 75% in 
Ethiopia, DOTs reach coverage of 90%(6, 7). 
DOTs given for at least the first two months of 
treatment, under the direct observation of health 
care providers has been found to be effective in 
achieving a highly successful treatment outcome 
ranging from 86 to 96.5% (8). Similarly, treatment 
success rate is considered as a proxy indicator of 
the quality of health care services, and it is usually 
affected by various reasons (6). 
Despite the existence of increment in 
treatment success rate in almost all of the studies 
done in Ethiopia (4, 6, 9-11), the average 
treatment success rate in most of them was below 
the MDG target (3). And,almost all were 
conducted before the year 2009. On top of these, 
we are left with almost a year for the 2015 MDG 
tuberculosis performance indicator target. 
Therefore, evaluating the treatment success rate of 
TB in DebreBerhanHospital is mandatory to show 
the achievement and to indicate where the hospital 
is against the WHO target by 2015.Thus, the aim 
of this study was todetermine treatment success 
rate of tuberculosis patients under anti-
tuberculosis treatment from January, 2009 to 
December 2013 in DebreBerhanHospital. 
Determining the treatment success rate of the 
hospital will help health planners and health 
professionals to show where they are relative to 
MDG tuberculosis target. In case if the TSR is 
under the target, it could lead them to identifying 
potential areas of improvement. This in turn could 
have its own role in  preventing  multidrug 
resistance (MDR-TB) and Xetensive drug 
resistance (XDR-TB) tuberculosis. 
 
METHODS AND PARTICIPANTS  
 
Study setting and design: Secondary data were 
collected from April to May 2014 from a 
registration book of TB patients who had been 
treated from January 2009 to December 2013 in 
DebreBerhanHospital, which is one of the four 
governmental hospitals in North Shewa Zone, 
Amhara Regional State, Ethiopia. 
DebreBerhanHospital is performing TB diagnosis, 
treatment and other related activities (VCT, 
prevention of mother to child transmission 
(PMTCT), antiretroviral therapy (ART) and 
opportunistic infections treatment services). A 
retrospective document review cross sectional 
study design was employed. 
Participants: All eligible TB patients who took 
anti-TB treatment from January 2009 to December 
2013 in DebreBerhanHospital were included in the 
study. Eligibility was based on completeness of 
record on treatment outcomes of a patient in the 
TB registration book and period of enrollment to 
DOTs treatment.  
Measurement: Tuberculosis treatment outcome 
was dichotomized as treatment success (cure or 
treatment completed as indicated in the unit TB 
register) or poor treatment outcome (treatment 
failure or death or defaulter or transferred out as 
indicated in the unit TB register). ‘Cured’ was 
defined as patients whose sputum smear or culture 
was positive at the beginning of the treatment but 
smear or culture negative in the last month of 
treatment and on at least one previous occasion. 
Similarly,‘treatmentcompleted’was interpreted as 
patients who completed treatment without 
evidence of failure but did not have a negative 
sputum smear or culture result in the last month of 
treatment and on at least one previous occasion. 
‘Treatmentdefaulter’defined as was a patient who 
had been on treatment for at least four weeks and 
whose treatment was interrupted for eight or more 
consecutive weeks. ‘Treatment failure’ was 
defined as patients whose sputum smear or culture 
was positive at the fifthmonthor later during 
treatment or patients found to harbor a multidrug-
resistant (MDR) strain at any point of time during 
the treatment whether they are smear negative or 
positive. Similarly, ‘transfer out’ was defined as a 
patient who had been transferred to another 
recording and reporting unit and whose treatment 
outcome was unknown at the original registering 
unit. 
Other variables included in the study were 
socio-demographic characteristics (age, sex, 
weight and residence), disease and services related 
factors (provider-initiated testing and counseling 
(PITC), HIV test result, ART, type of tuberculosis 
(PTB+, PTB-, and EPTB), category of TB patients 
(new, relapse, treatment after failure, return after 
default, transfer in), year of enrolment, 




followupsputum smear result at the second month, 
fifth month,  sixth month, eight month.  
TB patients’ records review were made for 
data extraction from the registration of the TB 
Clinic of the Hospital. Two nurses working at the 
TB slinicsin other health facilities and one 
supervisor who was TB officer in another district 
health office were recruited and trained for data 
extraction. The extraction of variables like 
demographic, disease related, health services 
related and treatment outcomes was undertaken 
using a checklist developed by the investigators. 
Sampling procedure: The sample size was 
calculated using single population proportion 
formula, by taking estimated average tuberculosis 
treatment success rate of 54% because treatment 
success rate ranges from 29.5-82.7% (2, 4, 6, 10-
12)  in Ethiopia. Considering95% Confidence 
level, 5% margin of error and finally with the 
addition of 15% non-response (incomplete records 
for treatment outcome) a total of 449tuberculosis 
patient recordswere required. However, since all 
the data were extracted from records and to 
increase the precision of the study, all TB patients 
of DebreBerhanHospital who started DOTs and 
had  complete medical records on treatment 
outcome in the past five years (January 2009 to 
December 2013) preceding the data collection 
period were included in the study. 
Data processing and analysis: Data were edited 
manually before entry to a computer and then 
entered to Epi-info version 3.2.2. Thereafter, they 
were cleaned, coded and analyzed using SPSS 
version 16 for windows. A descriptive analysis 
was conducted to get summary values of treatment 
outcome of TB and other explanatory variables as 
well as to check for outliers, inconsistencies and 
missed values. Finally, the results were presented 
in the form of tables and charts.  
Ethical consideration: Ethical clearance was 
obtained from the Health Research and 
Postgraduate Coordinating Office of the College 
of Public Health and Medical Sciences of Jimma 
University. Support letter was obtained from 
Jimma University to North Shewa Zone Health 
Department. Then, the Zonal Health Office wrote 
a letter of support to 
DebreBerhanReferralHospital. To ensure 
confidentiality of the information, names of TB 
patients were not included in the checklist and 
data were used only for research purpose. 
 
RESULT 
Demographic and disease related 
characteristics: Between January 2009 and 
December 2013, a total of 1830 tuberculosis 
patients were registered in the TB register unit of 
the hospital. Of these, 1280 (70%) tuberculosis 
cases had complete records on the treatment 
outcome. Among the total registered TB patients 
with complete record (n=1280), 649(50.7%) were 
males and the median age of patients was 28 
years. Near to one in ten of the study participants 
were children aged less than 15 years; near to 
seven in ten were adults with ages ranging from 
15 through 44 years. About 72% (n=930) of the 
patients were urban residents. Three in ten 
(29.6%) were smear positive PTB, nearly three 
fifth (56.6%) were smear negative PTB and the 
rest were EPTB patients. 1190(93%), 33 (2.6%), 
22(1.7%) and 35((2.7%) of TB patients were new, 
retreatment, transfer in and other cases, 
respectively. Seven in ten (70.9%) were offered 
provider-initiated testing and counseling for HIV, 















Table 1: Socio-demographic and disease related characteristics of registered TB patients (n=1280) in 
DebreBerhan referral Hospital, Jan. 2009 to Dec. 2013. 
 
 
Variable Categories Frequency Percentage (%)  
sex  Male 649 50.7  
 Female 631 49.3  
Age in years 0-14 141 
11.0 
 
 15-24 351 27.4  
 25-34 341 26.6  
 35-44 215 16.9  
 45-54 117 9.1  
 55-64 68 5.3  
 ≥65 47 3.7  
Residence Urban 930 72.7  
 Rural 350 27.3  
Type of TB PTB+ 379 29.6  
 PTB- 724 56.6  
 EPTB 177 13.8  
Category  
of TB patients 
New TB cases 1190 93.0  
Relapse cases 26 2.0  
Treatment after failure 2 0.2  
Return after default 5 0.4  
Transfer in  22 1.7  
Other  35  2.7  
Provider initiated testing and counseling offered   
 Yes 907 70.9  
No 
 
373 29.1  
HIV test result Positive  262 28.9  
 Negative 645 71.1  
 
 
Treatment Outcomes: From the total of 1280 
registered tuberculosis patients included in the 
study, 1016(79.4%) had successful treatment 
outcome (favorable treatment outcome). Of these, 
203(20%) and 813(80%) patients were cured and 
treatment completed, respectively. 
Similarly,135(10.5%), 102(8%), 23 (1.8%) and 
4(0.3%) were transferred out, defaulted, dead and 
treatment failed, respectively (Figure 1). 
 
Figure 1: Treatment outcomes of patients on 
DOTS treatment (n=1280) in DebreBerhan 
hospital from  Jan. 2009 to Dec. 2013, Ethiopia 
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Favorable treatment outcome slightly decreased 
from the year 2009 to 2010 (78.5 to75.9%) 
whereas starting from the end of 2010 to 2013, 
there was a continuous increment on favorable 
treatment outcome of TB (figure 2). Patients who 
completed their treatment slightly increased from 
58.5% in 2009 to 60.1% in 2010, but there was a 
decline to 56.4% in 2011. Later, treatment 
completed continuously rose from 56.4% in 2011 
to 75.3% in 2013. Similarly, the number of 
patients who were cured from tuberculosis 
decreased from 20% in 2009 to 15.8% in 2010 but 
again inclined to 20% in 2011. However, since 
then till 2013, a continuous decline was observed 
on cure rate. On top of these, treatment defaulting 
continuously increased from 6.9% in 2009 to 9.4% 





Figure 2: Trends of treatment outcomes of patients on 
DOTS treatment (n=1280) in DebreBerhan hospital 
from  Jan. 2009 to Dec. 2013, Ethiopia.
Table 2: Distribution of treatment outcomes of registered TB patients (n=1280) by socio-demographic and 
disease characteristics in DebreBerhanHospital, Jan. 2009 to Dec. 2013. 
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outcome N (%) 
Unfavorable outcome 
N (%) 
Total n (%) 
Sex  Male 511(78.7) 138(21.3) 649(100) 
 Female 505(80) 126(20) 631(100) 
Residence of patients Urban 753(81) 177(19) 930(100) 
 Rural 263(75.1) 87(24.9) 350(100) 
Age category 0-14 108(76.6) 33(23.4) 141(100) 
 15-24 278(79.2) 73(20.8) 351(100) 
 25-34 277(81.2) 64(18.8) 341(100) 
 35-44 176(81.9) 39(18.1) 215(100) 
 45-54 91(77.8) 26(22.2) 117(100) 
 55-64 52(76.5) 16(23.5) 68(100) 
 ≥65 34(72.3) 13(27.7) 47(100) 
Category  of TB patients New TB cases 950(79.8) 240(20.2) 1190(100) 
 Relapse Cases 22(84.6) 4(15.4) 26(100) 
 Treatment after 
Failure 
0 2(100) 2(100) 
 Return after default 3(60) 2(40) 5(100) 
 Transfer in 16(72.7) 6(27.3) 22(100) 
 Other 25(71.4) 10(28.6) 35(100) 
Type of TB PTB+ 309(81.5) 70(18.5) 379(100) 
 PTB- 567(78.3) 157(21.7) 724(100) 
 EPTB 140(79) 37(21) 177(100) 





Distribution of treatment outcome by socio-
demographic and disease characteristics: Five 
hundred eleven (78.7%) of the patients with 
favorable outcome, and 138(21.3%) of the patients 
with unfavorable outcome were male. Similarly, 
near to eight in ten of the patients with favorable 
outcome were urban in residence, new 
tuberculosis cases, pulmonary positive 
tuberculosis cases and pulmonary negative 
tuberculosis cases respectively (Table 2). 
DISCUSSION 
In this study, the average treatment success rate of 
tuberculosis patients was found to be 79.4%, and 
this was similar with an average of 80% in 
Southern Ethiopia (9),77% between 2005 and 
2011in New Delhi, India (13). However, this  was 
lower than the WHO international target of 87% 
by 2015 (3), 84% in Southern State of India in 
2011(14), 82.7% in Addis Ababa, Ethiopia (4), 
84.7% WHO report in 2005(15) and 94.8% in 
North West Ethiopia (12). This could be justified 
as population of Addis Ababa and India have 
better socio-demographic (educational) and 
economic condition than population in the 
catchment area of DebreBerhan in North Shewa 
Zone. This could also be as a result of difference 
in followup of patients and hence affects the 
outcome. On the contrary, the treatment success 
rate of this study was higher than an average of 
49% in Hadiya Zone, Southern Ethiopia (10) and 
55.7% in Gambella, Ethiopia (11). This could be 
justified as tuberculosis patients registered on the 
DOTs service between 2009 and 2013 were 
included in this study, which is relatively recent in 
time as compared to the previously mentioned 
studies. Hence, the quality of DOTs services and 
patients awarenessof the importance of TB 
treatment might have improved through time.  
There was a continuous increment of 
treatment success rate from the end of 2010 to 
2013 in the hospital. The treatment success rate in 
the year 2013 was 84.4%, which is almost 
comparable with the WHO international target of 
87% (3). This might be a clue indicating that the 
hospital is within the track of WHO target 
currently. 
The average cure rate of tuberculosis was 
15.9%. This was consistent with an average cure 
rate of 18% in Addis Ababa, Ethiopia (4) and 
18.7% in North West Ethiopia (12). However, this 
was lower than a finding from a study done in 
Gambella, Ethiopia (30.7%) (11). This was 
because participants in the Gambella study were 
pulmonary TB (PTB+ and PTB-) cases only 
whereas  both pulmonary and extra pulmonary 
tuberculosis cases were included in this study, 
which might underestimated the cure rate. 
Similarly, the average treatment completed rate 
was 63.5% in this study, which was in agreement 
with 64.6% according to study done in Addis 
Ababa, Ethiopia (4). However, it was higher than: 
9.5% in Gondar Hospital, Northwest Ethiopia (6), 
and 25% in Gambella, Ethiopia (11). This 
variation might be due to difference in 
patients’ enrollment time, patients registered 
in DOTs before the year 2009 were included 
in almost all of the previous studies unlike this 
study (in which patients registered between 
the year 2009 and 2013 were included). 
 As a result, the quality of DOTs services and 
patients’ awareness on the importance of DOTs 
treatment might become better through time.  
The average defaulting rate was 8%, which 
was lower than an average of 11.3% in Arsi Zone, 
Ethiopia (16), 18.3% in Gondar Hospital, 
Northwest Ethiopia (6)and 18.6% in Hadiya, 
Southern Ethiopia (10). This could be because of 
differences in followup and counseling of patients 
in DOTs clinics across these settings, suitability of 
the institutional setup and patient demographic 
characteristics(6, 10, 14, 17), knowledge and 
attitude towards and side-effect due to DOTs 
(16)and due to difference in patient enrollment 
time as mentioned above. On top of these, 
differences in communities’ beliefs on traditional 
healer or religious institutions for sick person 
might contribute to defaulting. However, the 
defaulting rate in this study was higher than 5.1% 
in a study done in Addis Ababa, Ethiopia (4). This 
might be due to differences in socio-demographic 
and economic status of more urbanized population 
in Addis Ababa as compared to the population in 
North Shewa Zone. 
In addition, 1.8% of the TB patients died 
between 2009 and 2013, which was consistent 
with an average of 2.6% in Hadiya, Southern 
Ethiopia (10), 3.7% in Addis Ababa, Ethiopia (4), 
and 3.4% in Northwest Ethiopia(12). However it 
was lower than 10.1% in Gondar Hospital, 
Northwest Ethiopia (6). The difference could be 




due to variation in HIV test offering status and 
anti-retroviral therapy initiation, participants 
in the study done in Gondar were TB patients 
who took DOTs from 2003 through 2008 in 
which the record did not show HIV test offer,  
test result and ART status (6)unlike in the 
current study ( near to 70.9% were offered 
HIV test counseling).Therefore, HIV positive 
TB cases can get anti-retroviral therapy and 
prevent mortality. On top of these, the average 
treatment failure rate was 0.3%, consistent 
with 0.2% in Gondar Hospital, Northwest 
Ethiopia (6), 0.4% in Addis Ababa, Ethiopia  (4), 
and 0.5% in Northest Ethiopia (12). 
Because of the large number of TB patients 
(30%) with unknown treatment outcome due 
to incomplete record, there might have been 
under or over estimation of favorable 
treatment outcome of tuberculosis. Thus, care 
should be taken when utilizing the finding of 
this study. In conclusion, the average 
treatment success rate of tuberculosis patients 
registered in the DOTs programme was lower 
than the WHO international target, whereas 
the treatment success rate in the year 2013 
was almost comparable with the WHO 
international target. This might be a clue 
indicating that the hospital is within the track 
of WHO target in 2015. Treatment completion 
rate increased unlike the cure rate and 
defaulting rate, which declined from 2011 
through 2013. Similarly, the average treatment 
completion rate of patients was relatively 
higher than the rateidentifiedprevious studies 
in Ethiopia. And, the average defaulting and 
death rates of the area in the given years were 
almost lower than similar studies in Ethiopia, 
which indicated better success of the hospital. 
There were improvements in the 
treatment success, defaulting and death rates. 
However, further effort should be done by 
responsible bodies to identify and improve 
possible promoting and hindering factors for 
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